These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 21532489)

  • 1. MxA RNA quantification in febrile patients who underwent hematopoietic cell transplantation for primary immunodeficiency.
    Ghidini C; Zanotti C; Boccacci S; Lanfranchi A; Caimi L; Imberti L
    Diagn Mol Pathol; 2011 Jun; 20(2):111-6. PubMed ID: 21532489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MxA expression in patients with viral infection after allogeneic stem cell transplantation.
    Yoshimasu T; Manabe A; Ebihara Y; Tanaka R; Ooi J; Iseki T; Shirafuji N; Maekawa T; Asano S; Yoshikawa N; Tsuji K
    Bone Marrow Transplant; 2003 Aug; 32(3):313-6. PubMed ID: 12858204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of MxA protein in blood lymphocytes discriminates between viral and bacterial infections in febrile children.
    Halminen M; Ilonen J; Julkunen I; Ruuskanen O; Simell O; Mäkelä MJ
    Pediatr Res; 1997 May; 41(5):647-50. PubMed ID: 9128286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral infections in juvenile myelomonocytic leukemia: prevalence and clinical implications.
    Manabe A; Yoshimasu T; Ebihara Y; Yagasaki H; Wada M; Ishikawa K; Hara J; Koike K; Moritake H; Park YD; Tsuji K; Nakahata T;
    J Pediatr Hematol Oncol; 2004 Oct; 26(10):636-41. PubMed ID: 15454834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MxA-based recognition of viral illness in febrile children by a whole blood assay.
    Nakabayashi M; Adachi Y; Itazawa T; Okabe Y; Kanegane H; Kawamura M; Tomita A; Miyawaki T
    Pediatr Res; 2006 Dec; 60(6):770-4. PubMed ID: 17065575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MxA protein in capillary blood of children with viral infections.
    Chieux V; Hober D; Chehadeh W; Harvey J; Alm G; Cousin J; Ducoulombier H; Wattre P
    J Med Virol; 1999 Dec; 59(4):547-51. PubMed ID: 10534740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective, comprehensive, and effective viral monitoring in children undergoing allogeneic hematopoietic stem cell transplantation.
    Schönberger S; Meisel R; Adams O; Pufal Y; Laws HJ; Enczmann J; Dilloo D
    Biol Blood Marrow Transplant; 2010 Oct; 16(10):1428-35. PubMed ID: 20399877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of viral infections using myxovirus resistance protein A (MxA).
    Engelmann I; Dubos F; Lobert PE; Houssin C; Degas V; Sardet A; Decoster A; Dewilde A; Martinot A; Hober D
    Pediatrics; 2015 Apr; 135(4):e985-93. PubMed ID: 25802344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human leucocyte antigen-identical haematopoietic stem cell transplantation in major histocompatiblity complex class II immunodeficiency: reduced survival correlates with an increased incidence of acute graft-versus-host disease and pre-existing viral infections.
    Renella R; Picard C; Neven B; Ouachée-Chardin M; Casanova JL; Le Deist F; Cavazzana-Calvo M; Blanche S; Fischer A
    Br J Haematol; 2006 Sep; 134(5):510-6. PubMed ID: 16848795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Observational prospective study of viral infections in children undergoing allogeneic hematopoietic cell transplantation: a 3-year GETMON experience.
    Verdeguer A; de Heredia CD; González M; Martínez AM; Fernández-Navarro JM; Pérez-Hurtado JM; Badell I; Gómez P; González ME; Muñoz A; Díaz MA;
    Bone Marrow Transplant; 2011 Jan; 46(1):119-24. PubMed ID: 20228849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic hematopoietic stem cell transplantation for seven children with X-linked hyper-IgM syndrome: a single center experience.
    Tomizawa D; Imai K; Ito S; Kajiwara M; Minegishi Y; Nagasawa M; Morio T; Nonoyama S; Mizutani S
    Am J Hematol; 2004 May; 76(1):33-9. PubMed ID: 15114594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of MxA protein in blood lymphocytes of children receiving anticancer chemotherapy.
    Koskenvuo MM; Halminen M; Blomqvist M; Vainionpää R; Ilonen J; Julkunen I; Salmi TT; Mäkelä MJ
    Pediatr Hematol Oncol; 2006 Dec; 23(8):649-60. PubMed ID: 17065141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of neutralizing antibodies to therapeutic interferon-beta in multiple sclerosis patients: a comparison of three methods in a large Australasian cohort.
    McKay F; Schibeci S; Heard R; Stewart G; Booth D
    J Immunol Methods; 2006 Mar; 310(1-2):20-9. PubMed ID: 16448664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis, surveillance, and epidemiologic evaluation of viral infections in pediatric cardiac transplant recipients with the use of the polymerase chain reaction.
    Schowengerdt KO; Ni J; Denfield SW; Gajarski RJ; Radovancevic B; Frazier HO; Demmler GJ; Kearney D; Bricker JT; Towbin JA
    J Heart Lung Transplant; 1996 Feb; 15(2):111-23. PubMed ID: 8672514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenoviral infection after allogeneic stem cell transplantation (SCT): report on 130 patients from a single SCT unit involved in a prospective multi center surveillance study.
    Runde V; Ross S; Trenschel R; Lagemann E; Basu O; Renzing-Köhler K; Schaefer UW; Roggendorf M; Holler E
    Bone Marrow Transplant; 2001 Jul; 28(1):51-7. PubMed ID: 11498744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory viral infections in children with leukemia.
    Koskenvuo M; Möttönen M; Rahiala J; Saarinen-Pihkala UM; Riikonen P; Waris M; Ziegler T; Uhari M; Salmi TT; Ruuskanen O
    Pediatr Infect Dis J; 2008 Nov; 27(11):974-80. PubMed ID: 18833026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-beta bioactivity measurement in multiple sclerosis: feasibility for routine clinical practice.
    van der Voort LF; Kok A; Visser A; Oudejans CB; Caldano M; Gilli F; Bertolotto A; Polman CH; Killestein J
    Mult Scler; 2009 Feb; 15(2):212-8. PubMed ID: 18805837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type I interferon response against viral and non-viral gene transfer in human tumor and primary cell lines.
    Rautsi O; Lehmusvaara S; Salonen T; Häkkinen K; Sillanpää M; Hakkarainen T; Heikkinen S; Vähäkangas E; Ylä-Herttuala S; Hinkkanen A; Julkunen I; Wahlfors J; Pellinen R
    J Gene Med; 2007 Feb; 9(2):122-35. PubMed ID: 17191255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical consequences and treatment of primary immunodeficiency syndromes characterized by functional T and B lymphocyte anomalies (combined immune deficiency).
    Berthet F; Le Deist F; Duliege AM; Griscelli C; Fischer A
    Pediatrics; 1994 Feb; 93(2):265-70. PubMed ID: 8121739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.